Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page
Users Online:: 444
ORIGINAL ARTICLE
Year : 2007  |  Volume : 10  |  Issue : 1  |  Page : 15-18

Transfusion associated hepatitis B virus infection among sickle cell anaemia patients in Kano, Nigeria


1 Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria
2 Department of Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria

Correspondence Address:
A Kuliya-Gwarzo
Department of Haemctoico», Aminu Kano Teaching Hospital, PMB 3452, Kano
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Background: Transfusion of blood products is a recognised way of transmitting infections particularly viruses. The extent to which blood transfusion contributes to hepatitis B virus (HBV) infections in transfused patients with sickle cell anaemia (SCA) has been found to be 20% in Lagos, Nigeria. Manxman in Zaria however reported a lower prevalence of 4.03%. This wide variation in prevalence might not be unconnected with patients' selection, methodology or differences in quality control at transfusion. Objective: This study was aimed at determining the prevalence of transfusion associated HBV infection among sickle cell anaemia patients in Kano, Nigeria. Materials and Methods: The study was a case control study in which patients with sickle cell anaemia were recruited from Aminu Kano Teaching Hospital (AKTH), Murtala Mohammed Specialist Hospital (MMSH) and Hasiya Bayero Paediatric Hospital (HBBH), all within Kano metropolis, Kano, Nigeria. A total of 135 consecutive patients with Sickle Cell Anaemia (SCA) {68 transfused (cases) and 67 non transfused (controls)} were studied. An interviewer administered questionnaire containing details of previous blood transfusion and other risk factors for HBV infections was administered to each of the patients. The presence of HBsAg was then looked for in both the transfused (cases) and non transfused (controls) patients with SCA using Monolisa ELISA according to manufacturers instructions. The association between multiple blood transfusions and the risk of HBV infection was determined by calculating the relative and attributable risks respectively. Results: There were 68 patients in the study group (cases) consisting of 41(60.3%) males and 27(39.7%) females while the controls were made up of 67 patients consisting of 24(35.8%) males and 43(64.2%) females. Eighteen patients (26.5%) in the transfused group and 3(4.5%) in the control group tested positive for HBsAg. Blood transfusion was significantly associated with HBV infection in patients with SCA (p<0.05) with a Relative Risk (RR) of 5.8 and an Attributable Risk (AR) of 22%. Conclusion: There still exist increased risks of infection with HBV in SCA patients who have received blood transfusion despite existing screening modalities. Therefore polices aimed at effective prevention like ensuring quality control, standardizing and centralizing blood transfusion services need to be put in place as a matter of urgency.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1070    
    Printed34    
    Emailed0    
    PDF Downloaded97    
    Comments [Add]    

Recommend this journal